Menu

Recent Interviews

Alison Coutts, Executive Chairman, Memphasys Ltd.

Alison Coutts
Executive Chairman | Memphasys Ltd.
30 Richmond Road, 2140 Homebush West (AUS)

alison.coutts@memphasys.com

+61 2 8415 7300

Memphasys Executive Chairman Alison Coutts on in vitro fertilisation (IVF)


Thomas Soltau, CEO, wallstreet:online capital AG

Thomas Soltau
CEO | wallstreet:online capital AG
Michaelkirchstraße 17/18, 10179 Berlin (D)

service@smartbroker.de

+49 30 27 57 76 464

Smartbroker - wallstreet:online capital AG CEO Thomas Soltau in an interview on the market launch


Jonathan Summers, CEO, EXMceuticals Inc.

Jonathan Summers
CEO | EXMceuticals Inc.
1111 Alberni Street, Suite 1603, V6E 4V2 Vancouver (CAN)

jonathan@exmceuticals.com

EXMceuticals CEO Jonathan Summers on the medical cannabis market


13. January 2020 | 11:33 CET

Agrios Global Holdings LTD - still on track

  • Cannabis

Agrios Global Holdings is an agricultural technology company with a focus on the latest innovations in indoor growing and data analytics. The company's technology can be used for all types of indoor cultivation. The company rents and manages real estate and equipment for environmentally sustainable indoor agriculture. The company offers leasing and cultivation services in the field of data-controlled aeroponic cultivation systems for cannabis producers. Furthermore, the company provides consulting services to support the cannabis sector.

time to read: 1 minutes by Mario Hose


Jonathan Summers, CEO, EXMceuticals Inc.
"[...] In being able to grow in some of the best natural conditions in the world along the equator, Africa offers enormous advantages for cannabis cultivation. [...]" Jonathan Summers, CEO, EXMceuticals Inc.

Zum Interview


Meet decision makers in your locality on
www.meet-the-management.com

Subscribe now

 

Update to the cannabis market

Agrios Global Holdings (Agrios) is still a young company with high growth potential, according to the experts at GBC Research. The company currently owns a state-of-the-art production facility in Washington State, which is leased to a licensed cannabis producer and processor. Agrios also leases data-driven aeroponics cultivation systems and cultivation services to cannabis producers. The company's technology can also be used for any type of indoor cultivation.

The US Indoor Aeroponics market is expected to reach USD 40 billion annually by 2022. In addition, the US cannabis market is estimated to reach USD 75 billion annually by 2030. The market in the state of Washington was still around USD 1.37 billion in 2017 and is expected to grow to USD 2.28 billion by 2020.

Sales increase compared to the previous year

Agrios Holdings recorded an increase in its product and service revenues and a slight increase in rental / IP revenues in the second quarter of fiscal 2019/2020, which ends March 31, 2020, representing a total increase of 8.54% over the previous quarter to USD 1.093 million compared to USD 1.007 million in the previous quarter.

Revenues must increase significantly in Q3 and Q4 of the current 2019/2020 financial year in order to meet GBC Research's overall year guidance.

Still on track

For the current financial year 2019/2020e, analysts at GBC had previously forecast a small negative after-tax result of USD 1.5 million. They had expected the company to report negative cash flows in the first two quarters of the current 2019/2020 financial year. Only from the third quarter onwards should the operating cash flow turn positive. The company is well on the way to meeting these expectations.

In the second quarter of 2019, EBITDA was USD -0.524 million, a significant improvement on the previous year's USD -1.789 million. EBIT also showed significant improvements and amounted to USD -0.615 million, which is significantly above the previous year's level of USD -1.843 million. The experts at GBC have raised their price target from CAD 1.38 to CAD 1.64 and confirmed the BUY rating.


Conflict of interest & risk note

In accordance with §34b WpHG we would like to point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH may hold shares in the aforementioned companies and that there may therefore be a conflict of interest. Further details can be found in our Conflict of Interest & Risk Disclosure.


Related comments:

23. March 2020 | 15:00 CET

Aurora Cannabis, Bayer, EXMceuticals - ready for the time after Corona

  • Cannabis

The cannabis hype was over and then came the corona crisis. Investors who believed in the active ingredient of cannabis and put money into the shares of companies in this industry are now likely to be sitting on a huge loss in most cases. It all started with the idea of a few companies to make one of the oldest medicinal plants in the world acceptable for general use within the framework of legalization. However, high margins and a large market soon led to competition and a brokerage industry was earning a lot of money - soon several hundred cannabis companies were listed on the stock exchange.

Read

25. February 2020 | 13:38 CET

Aurora Cannabis, Canopy Growth, EXMceuticals - who will be the best turnaround story?

  • Cannabis

Cannabis shares are not in demand at the moment. About a year ago the growth potential and possibilities of the rediscovered historical medicinal plant seemed to be endless. Today it is different, there is a hangover mood. The hype back then led to a buyer's market. Investors underbid each other with purchase orders and shareholders surrendered their shares in a nervous mood in order to set off for new shores. This or something similar may be the current situation in the environment of numerous cannabis companies. But experienced investors also know that consolidation phases are the foundation for success stories.

Read

11. February 2020 | 14:55 CET

Aphria, Canopy Growth, EXMceuticals - Europe becomes the largest cannabis market

  • Cannabis

The consulting firm Prohibition Partners expects Europe to grow into the world's largest market for legal cannabis products in the next five years. Germany will become by far the largest market for medical cannabis products. According to the experts, Europe will thus overtake the North American market.

Read